Navigation Links
Five New Clinical Studies Show Value of Masimo PVI & PI
Date:10/17/2008

to the 'gold standard' measure-through-motion-and-low-perfusion performance of Masimo SET(R) Oxygen Saturation (SpO2), Pulse Rate (PR) and Perfusion Index (PI).

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at http://www.masimo.com.

Forward Looking Statements

This press release includes forward-looking statements as defined in Sect
'/>"/>

SOURCE Masimo
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
2. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
3. ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development
4. Sysmex Announces Clinical Laboratory Software Name Change
5. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
6. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
7. Covance Decides to Pursue Its Original Preclinical Strategy in China
8. Satyam Partners with Oracle to Provide Clinical Development Applications
9. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
10. Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
11. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... San Diego, Calif. (PRWEB) June 02, 2015 ... developer of build-to-order, independent blade-based and rackmount computing ... centers, today announced the launch of its high ... offering, the Cirrascale Slipstream™ RM1622D . The ... Xeon® processor E3-1200 v4 product family with Intel® ...
(Date:6/2/2015)... PAULO , June 2, 2015   Hospira, ... in biosimilars, today announced that its partner, Celltrion – a ... – the National Health Surveillance Agency in ... biosimilar monoclonal antibody approved for use in ... Hospira. Hospira also markets and sells biosimilar infliximab in ...
(Date:6/2/2015)... 2015   Y-Prime, Inc ., announced today ... 2015 in Philadelphia , June ... gathering, allows influential decision makers from the Biotech ... evaluate emerging technologies such as YPrime. ... design, implementation and management of Interactive Response Technology ...
(Date:6/2/2015)... 2015 “Stem Cell Therapy to help dogs ... it is used often as an adjunct to surgery in ... not yet aware or comfortable enough with the techniques to ... often reserved for the last resort cases - when nothing ... lift a paw to get around. It is an easy ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3
... February 5 HOYA Corporation today,announced financial results for ... 112.7 billion yen for the quarter, representing a decrease ... of 2007, mainly due to,order decrease and the drop ... the main business fields such as the Electro-Optics and,Vision ...
... CHAPEL HILL, N.C., Feb. 5 In today,s ... focusing on,strategy and tactics to drive growth and ... resources dedicated by biopharmaceutical companies to,support marketing operations, ... LLC, with insights available in the newly published ...
... Feb. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences ... that on February 2, 2009 it received a letter ... the Company that the Panel has determined to grant ... Capital Market. The Panel granted the Company through ...
Cached Biology Technology:Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008 2New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth 2Nasdaq Panel Grants Advanced Life Sciences Request for Continued Listing on Nasdaq Stock Market 2
(Date:6/1/2015)... DALLAS , June 1, 2015 ... Recognition & Touchless Sensing Market by Technology (Touch-based & ... & Sanitary Equipment), & by Geography - Global Forecast ... Touchless Sensing Market is expected to reach $23.55 Billion ... and 2020. Browse 83 market data ...
(Date:6/1/2015)... DALLAS , June 1, 2015 ... report "Next Generation Biometrics Market by Application (Government, ... Electronics, Travel & Immigration, and Security), Technology (Face ... Recognition, Signature Recognition, Vein Recognition, and Others), Function ... America , Europe , ...
(Date:5/29/2015)... , May 28, 2015 Research ... addition of the "Facial Recognition Market by ... - Global Forecast to 2020" report to ... have seen facial recognition technology become more efficient ... to gain traction and investment from the commercial ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... review, recently published in Critical Reviews in Food ... increase food intake or impact body weight or blood ... The review examined data regarding the normal consumption of ... or and/or glucose metabolism or weight gain in overweight ...
... today at the 31st Annual meeting of the Society for ... three proteins known as XIAP, BID, and Bcl-2 are responsible ... prevention of preterm labor. They may also play an ... proteins prevent preterm birth by hindering apoptosis the normal, ...
... Feb. 10, 2011 Aethlon Medical, Inc. (OTC Bulletin ... therapeutic filtration devices to address infectious disease and cancer, ... to present at the 4th Congress of the International ... his presentation is "The Treatment of HCV with Affinity ...
Cached Biology News:Extensive research demonstrates fructose does not increase food intake or impact weight 2Extensive research demonstrates fructose does not increase food intake or impact weight 3New research helps explain how progesterone prevents preterm birth 2Aethlon Medical to Present at 4th Congress of the International Society for Hemodialysis in India 2Aethlon Medical to Present at 4th Congress of the International Society for Hemodialysis in India 3Aethlon Medical to Present at 4th Congress of the International Society for Hemodialysis in India 4Aethlon Medical to Present at 4th Congress of the International Society for Hemodialysis in India 5
...
...
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide....
... and analysis software for electrophysiology ... Contains powerful stimulus generation capabilities ... including automated waveform feature detection ... many electrophysiology specific functions including ...
Biology Products: